PPARG and metabolic dysfunction-associated steatotic liver disease: Many studies have suggested that rosiglitazone and pioglitazone indirectly improve NAFLD through enhancing fatty acid uptake and adiponectin secretion of the adipose tissue, which is the main organ that express the PPARγ [7, 8].